Entertainment Quad to Announce Q2 2025 Results and Host Conference Call Quad/Graphics, Inc. (NYSE: QUAD), a prominent marketing experience company, has announced that it will release its financial results for the second quarter and year-to-date... Editorial5 hours ago
Health First Patient Dosed in Clinical Study of Novel Cancer Therapy On July 9, 2025, Avenzo Therapeutics, Inc. announced that the first patient has been dosed in a Phase 1 clinical trial for AVZO-1418/DB-1418, a... Editorial15 hours ago